UncategorizedDyno Therapeutics unveils Dyno‑bn8 AAV vector for muscle gene therapies – Longevity.Technology Empower Meds / November 13, 2025
UncategorizedTelomir Pharmaceuticals sees Telomir-1 outperform standard iron chelator DFO in cell study – Longevity.Technology Empower Meds / November 13, 2025
UncategorizedMedley Therapeutics’ YAP101 gene therapy passes first safety milestone – Longevity.Technology Empower Meds / November 13, 2025
UncategorizedHotel The Lake Como EDITION opens bringing luxury wellness to iconic Italian lakefront – Longevity.Technology Empower Meds / November 13, 2025
UncategorizedAlterity Therapeutics reports ATH434 efficacy signal in MSA trial – Longevity.Technology Empower Meds / November 12, 2025
UncategorizedShift Bioscience unveils new metric‑calibration framework for AI‑virtual‑cell models – Longevity.Technology Empower Meds / November 12, 2025
UncategorizedCND Life Sciences’ Syn-One® biomarker services used in Phase 2 Parkinson’s trial – Longevity.Technology Empower Meds / November 12, 2025
